| Name | Title | Contact Details |
|---|
CellMax Life is revolutionizing early cancer detection, prevention and management.
BioPorto s flagship product, The NGAL Test™, aids in the risk assessment of AKI in critically ill patients. CE marked for IVD use in select regions.
Altea Therapeutics Corporation is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Iovance Biotherapeutics is a biopharmaceutical startup based in San Carlos, California.
ArrePath is a biotech company discovering and developing new and differentiated classes of anti-infectives to address antimicrobial resistance (AMR) through the application of state of the art technologies and novel strategies.